What question did this study set out to answer?

Characterize the clinical utility and diagnostic impact of targeted RNA sequencing compared to chromosome banding analysis in myeloid and immature lymphoid malignancies.

February 26, 2025Blood AdvancesOpen Access

Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies

View Full Paper

Ask AI

Bookmark

Authors

MZMelissa ZhaoBrigham and Women's Hospital SRScott RyallHarvard University Press SBSam J. BrodyBrigham and Women's Hospital

Discussion

Member takes

Implication

Cohort study reveals chromosomal mimicry in hematologic cancers, highlighting the diagnostic necessity of gene-level targeted RNA sequencing.

Key Points

Characterize the clinical utility and diagnostic impact of targeted RNA sequencing compared to chromosome banding analysis in myeloid and immature lymphoid malignancies.
Evaluated a cohort of 380 tumors (87% myeloid, 13% immature lymphoid) using chromosome banding analysis (CBA) alongside anchored multiplex polymerase chain reaction (AMP)-targeted RNA sequencing.
Classified structural variants into a 5-tier clinical significance system ranging from established clinical impact (tier 1) to no variants detected (tier 5).
Integrating AMP-targeted RNA sequencing with traditional CBA improved the identification of clinically relevant (tier 1 or tier 2) variants in 10% of cases.
Identified chromosomal mimicry in 1% (3/380) of patients, wherein CBA detected apparent classic structural variants—such as t(9;22)(q34;q11.2)—that failed to demonstrate expected gene-level fusions on molecular testing.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/6a16eec025571367076bc279 https://doi.org/10.1182/bloodadvances.2024013800

View Full Paper

Ask AI

Bookmark

February 26, 2025Blood AdvancesOpen Access

Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies

View Full Paper

Ask AI

Bookmark

Authors

MZMelissa ZhaoBrigham and Women's Hospital SRScott RyallHarvard University Press SBSam J. BrodyBrigham and Women's Hospital

Discussion

Member takes

Implication

Cohort study reveals chromosomal mimicry in hematologic cancers, highlighting the diagnostic necessity of gene-level targeted RNA sequencing.

Key Points

Characterize the clinical utility and diagnostic impact of targeted RNA sequencing compared to chromosome banding analysis in myeloid and immature lymphoid malignancies.
Evaluated a cohort of 380 tumors (87% myeloid, 13% immature lymphoid) using chromosome banding analysis (CBA) alongside anchored multiplex polymerase chain reaction (AMP)-targeted RNA sequencing.
Classified structural variants into a 5-tier clinical significance system ranging from established clinical impact (tier 1) to no variants detected (tier 5).
Integrating AMP-targeted RNA sequencing with traditional CBA improved the identification of clinically relevant (tier 1 or tier 2) variants in 10% of cases.
Identified chromosomal mimicry in 1% (3/380) of patients, wherein CBA detected apparent classic structural variants—such as t(9;22)(q34;q11.2)—that failed to demonstrate expected gene-level fusions on molecular testing.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/6a16eec025571367076bc279 https://doi.org/10.1182/bloodadvances.2024013800

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark